SCHEMBL1032675

SCHEMBL1032675

Cc1ccc(-c2ccnc(NC3CCCCC3)n2)cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 7/20 0.59
CCNB1 P14635 7/20 0.59
CDK4 P11802 3/20 0.59
CCNA2 P20248 3/20 0.59
CCND1 P24385 3/20 0.59
CDK2 P24941 3/20 0.59
CCNA1 P78396 3/20 0.59
MAPK8 P45983 4/20 0.56
MAPK9 P45984 4/20 0.56
MAPK10 P53779 4/20 0.56
HDAC8 Q9BY41 1/20 0.55
CCNE1 P24864 1/20 0.53
CCND3 P30281 1/20 0.53
CDK6 Q00534 1/20 0.53
CCNB2 O95067 4/20 0.52
CCNB3 Q8WWL7 4/20 0.52
IKBKB O14920 4/20 0.51
CDC7 O00311 1/20 0.51
PLK4 O00444 1/20 0.51
JAK2 O60674 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18412505 0.83 HDAC8 (0.50) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1033674 0.83 CDK1 (0.57) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL18412499 0.81 HDAC8 (0.49) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1032690 0.80 KDM4E (0.50) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1032138 0.80 IKBKB (0.76) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1033987 0.80 IKBKB (0.56) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1029919 0.80 IKBKB (0.57) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1034820 0.80 CDK4 (0.57) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL3748251 0.80 PTGS2 (0.69) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL18412509 0.80 HDAC8 (0.45) CDK1CCNB1CDK4CCNA2CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed